stability of reconstituted ghk-cu peptide 50mg vs 100mg: Which Vial Size Is Right for Your Research? GHK-Cu – Pepturion
Description
This is consistent with tolerance of K1A substitution in human Amy (hAmy) for cAMP potency at AMYRs 18
Neither is an FDA-approved drug for human therapeutic indications
Researchers should note this distinction when transitioning between different peptide protocols
Keep the vial protected from direct light
